In osteosarcoma, and Liu et al. [27] indicated that the knockdown of ROCK1 could inhibit proliferation and induces apoptosis in osteosarcoma cell lines and high levels of ROCK1 were associated with poor outcomes in clinical osteosarcoma, which was consistent with our findings. The gene discussed is ROCK1; the disease is osteosarcoma.